History of GC Group.
Great Capabilities
Immunoglobulin on a global scale
GC is committed to improving the lives of people around the world and has built a global network of professionals and facilities to make this a reality. We have a worldwide reach, with an operational presence in 5 countries on three continents.
A global reach
With over 5000 employees, GC has the world’s 5th largest plasma manufacturing capacity, with offices in South Korea, China, Hong Kong, Brazil, and the United States.
North America
U.S. Commercial Headquarters
GC Biopharma USA, Inc. established the corporate sales and commercial business office in Teaneck, NJ.
U.S. R&D Offices
Established in Seattle, WA, and San Diego, CA, GC launched new research and development facilities focused on vaccine development and new oncology based natural killer cell therapy.
South America
South America Commercial Headquarters
San Paulo, Brazil is the headquarters for GC’s South American operations.
Asia
GC Group Headquarters
Based just outside Seoul, South Korea, GC employs more than 5000 people and is the largest plasma manufacturer in Asia.
GC Plasma Centers
GC growth through Asia led to establishing plasma facilities throughout South Korea and China.
Manufacturing Facilities
GC Biopharmaceutical and plasma manufacturing facilities: South Korea (3) and China (2).
Sales and Business Operations
South Korea, Hong Kong, and China.
Throughout its history, which spans half a century, GC has developed the field of specialty pharmaceuticals, with a focus on plasma-derived drug products. GC is devoted to developing new drugs to achieve its mission and vision.
